Cytosorbents Corp - COM NEW (CTSO)

Historical Portfolio Holders from Q4 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
16.4M
Holdings value Q3 2024
$24.6M
Value change Q3 2024
-$179K
Grand Portfolio weight change Q3 2024
0%
Number of holders
51
Number of buys Q3 2024
16
Number of sells Q3 2024
-15
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 16.4M $24.6M -$179K $1.50 51
2024 Q2 16.4M $11.5M -$649K $0.70 44
2024 Q1 17.5M $16.6M -$405K $0.95 47
2023 Q4 17.9M $19.9M +$3.21M $1.11 50
2023 Q3 15.2M $28.5M -$160K $1.88 51
2023 Q2 15.2M $54.5M +$138K $3.59 57
2023 Q1 15.1M $51.1M +$1.68M $3.37 57
2022 Q4 14.6M $22.6M -$46K $1.55 48
2022 Q3 13.7M $18.7M -$1.56M $1.36 52
2022 Q2 15.5M $33.9M -$6.12M $2.19 68
2022 Q1 18M $57.5M +$256K $3.19 82
2021 Q4 17.8M $74.5M -$8.09M $4.19 90
2021 Q3 18.4M $149M +$6.98M $8.12 93
2021 Q2 17.5M $132M -$233K $7.55 97
2021 Q1 17.5M $152M -$2M $8.68 92
2020 Q4 17.6M $140M +$3.07M $7.97 89
2020 Q3 17.2M $137M +$46.4M $7.98 94
2020 Q2 11.2M $111M +$14.1M $9.90 91
2020 Q1 9.94M $76.8M +$8.99M $7.73 79
2019 Q4 8.94M $34.4M +$1.51M $3.85 70
2019 Q3 8.44M $42.5M -$1.06M $5.03 66
2019 Q2 8.51M $56.3M +$526K $6.61 68
2019 Q1 8.51M $64.4M -$1.16M $7.57 72
2018 Q4 8.66M $69.9M +$1.13M $8.08 83
2018 Q3 8.2M $106M +$5.08M $12.90 80
2018 Q2 7.8M $88.9M +$45.8M $11.40 74
2018 Q1 3.92M $27.7M +$5.32M $7.05 47
2017 Q4 3.21M $20.8M +$4.72M $6.50 44
2017 Q3 2.48M $15.4M +$3.73M $6.20 32
2017 Q2 1.94M $8.34M -$2.32M $4.30 30
2017 Q1 2.45M $11.1M +$4.37M $4.50 34
2016 Q4 1.59M $8.69M +$47.1K $5.45 37
2016 Q3 1.57M $10M -$1.21M $6.40 35
2016 Q2 1.77M $8.06M +$411K $4.55 33
2016 Q1 1.41M $5.51M +$7.42K $3.92 32
2015 Q4 1.38M $7.66M -$95.3K $5.57 38
2015 Q3 1.35M $8.52M +$674K $6.30 34
2015 Q2 1.24M $7.63M +$745K $6.14 29
2015 Q1 902K $11.9M +$7.84M $13.19 27
2014 Q4 394K $3.92M +$1.05M $9.96 9